1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 Bhaskaran, R. Huang, C.C. Chang, K.D. Yu, C. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic 1 90.00 90.00 90.00 1.000 1.000 1.000 C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C3 H7 N O2 S 121.158 y CYSTEINE L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C5 H11 N O2 S 149.211 y METHIONINE L-peptide linking C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking US J.Biol.Chem. JBCHA3 0071 0021-9258 269 23500 23508 8089116 Cardiotoxin II from Taiwan cobra venom, Naja naja atra. Structure in solution and comparison among homologous cardiotoxins. 1994 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 6760.242 CARDIOTOXIN II 1 man polymer no no LKCNKLVPLFYKTCPAGKNLCYKMFMVSNLTVPVKRGCIDVCPKNSALVKYVCCNTDRCN LKCNKLVPLFYKTCPAGKNLCYKMFMVSNLTVPVKRGCIDVCPKNSALVKYVCCNTDRCN A polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n Chinese cobra Naja sample 8656 Naja atra pdbx_database_status pdbx_struct_assembly pdbx_struct_oper_list struct_conf repository Initial release Version format compliance Version format compliance Derived calculations Other 1 0 1994-05-31 1 1 2008-03-24 1 2 2011-07-13 1 3 2017-11-29 _pdbx_database_status.process_site Y BNL 1994-03-12 REL 1 BRUNGER refinement X-PLOR LEU 1 n 1 LEU 1 A LYS 2 n 2 LYS 2 A CYS 3 n 3 CYS 3 A ASN 4 n 4 ASN 4 A LYS 5 n 5 LYS 5 A LEU 6 n 6 LEU 6 A VAL 7 n 7 VAL 7 A PRO 8 n 8 PRO 8 A LEU 9 n 9 LEU 9 A PHE 10 n 10 PHE 10 A TYR 11 n 11 TYR 11 A LYS 12 n 12 LYS 12 A THR 13 n 13 THR 13 A CYS 14 n 14 CYS 14 A PRO 15 n 15 PRO 15 A ALA 16 n 16 ALA 16 A GLY 17 n 17 GLY 17 A LYS 18 n 18 LYS 18 A ASN 19 n 19 ASN 19 A LEU 20 n 20 LEU 20 A CYS 21 n 21 CYS 21 A TYR 22 n 22 TYR 22 A LYS 23 n 23 LYS 23 A MET 24 n 24 MET 24 A PHE 25 n 25 PHE 25 A MET 26 n 26 MET 26 A VAL 27 n 27 VAL 27 A SER 28 n 28 SER 28 A ASN 29 n 29 ASN 29 A LEU 30 n 30 LEU 30 A THR 31 n 31 THR 31 A VAL 32 n 32 VAL 32 A PRO 33 n 33 PRO 33 A VAL 34 n 34 VAL 34 A LYS 35 n 35 LYS 35 A ARG 36 n 36 ARG 36 A GLY 37 n 37 GLY 37 A CYS 38 n 38 CYS 38 A ILE 39 n 39 ILE 39 A ASP 40 n 40 ASP 40 A VAL 41 n 41 VAL 41 A CYS 42 n 42 CYS 42 A PRO 43 n 43 PRO 43 A LYS 44 n 44 LYS 44 A ASN 45 n 45 ASN 45 A SER 46 n 46 SER 46 A ALA 47 n 47 ALA 47 A LEU 48 n 48 LEU 48 A VAL 49 n 49 VAL 49 A LYS 50 n 50 LYS 50 A TYR 51 n 51 TYR 51 A VAL 52 n 52 VAL 52 A CYS 53 n 53 CYS 53 A CYS 54 n 54 CYS 54 A ASN 55 n 55 ASN 55 A THR 56 n 56 THR 56 A ASP 57 n 57 ASP 57 A ARG 58 n 58 ARG 58 A CYS 59 n 59 CYS 59 A ASN 60 n 60 ASN 60 A author_defined_assembly 1 monomeric 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 identity operation 0.0000000000 0.0000000000 0.0000000000 1 A A HE1 HB3 TYR TYR 22 51 0.92 1 A A HG22 HD3 VAL PRO 7 8 0.94 1 A A O H ASP CYS 57 59 1.05 1 A A HD22 HD21 LEU ASN 20 55 1.09 1 A A HB3 H LYS THR 12 13 1.19 1 A A HD21 HB2 LEU ASN 20 55 1.20 1 A A HB3 H ASP ARG 57 58 1.23 1 A A H HD2 VAL PRO 7 8 1.29 1 A A HD3 NH1 LYS ARG 23 36 1.39 1 A A O HE1 VAL TYR 49 51 1.40 1 A A H O LYS ASN 2 60 1.46 1 A A HA C LEU ASN 1 60 1.48 1 A A C HD1 LYS TYR 50 51 1.56 1 A A O HD22 ASN ASN 19 60 1.57 1 A A HG2 O LYS CYS 18 38 1.58 1 A A O HE1 VAL PHE 7 10 1.59 1 A A O N ASP CYS 57 59 1.63 1 A A N O LYS ASN 2 60 1.63 1 A A C O LEU ASN 1 60 1.77 1 A A CA O LEU ASN 1 60 1.89 1 A A O CE1 VAL PHE 7 10 2.03 1 A ARG 36 0.160 SIDE CHAIN 1 A ARG 58 0.315 SIDE CHAIN 1 A LEU 6 66.33 -144.42 1 A VAL 7 -126.13 -51.40 1 A LEU 9 -134.42 -40.23 1 A PHE 10 59.90 177.72 1 A TYR 11 -140.94 -90.06 1 A LYS 12 158.24 -113.05 1 A ALA 16 87.88 135.87 1 A ASN 19 -154.83 -23.09 1 A PHE 25 -160.63 -166.11 1 A SER 28 -158.16 -60.92 1 A ASN 29 -123.75 -61.51 1 A LEU 30 -146.98 59.50 1 A THR 31 54.56 72.12 1 A LYS 44 70.59 164.41 1 A ASN 45 -157.57 -131.50 1 A SER 46 178.74 -130.38 1 A ALA 47 -144.23 -23.86 1 A ASN 55 -159.69 42.05 1 A THR 56 -162.40 94.22 1 A ASP 57 63.78 -133.29 1 A ARG 58 -14.14 -11.61 model building X-PLOR refinement X-PLOR phasing X-PLOR CARDIOTOXIN II (NMR, MINIMIZED AVERAGE STRUCTURE) CARDIOTOXIN II FROM TAIWAN COBRA VENOM, NAJA NAJA ATRA: STRUCTURE IN SOLUTION AND COMPARISION AMONG HOMOLOGOUS CARDIOTOXINS 1 Y N disulf 2.020 A CYS 3 A SG CYS 3 1_555 A CYS 21 A SG CYS 21 1_555 disulf 2.019 A CYS 14 A SG CYS 14 1_555 A CYS 38 A SG CYS 38 1_555 disulf 2.021 A CYS 42 A SG CYS 42 1_555 A CYS 53 A SG CYS 53 1_555 disulf 2.020 A CYS 54 A SG CYS 54 1_555 A CYS 59 A SG CYS 59 1_555 CARDIOTOXIN CARDIOTOXIN CTX2_NAJAT UNP 1 1 P01442 MKTLLLTLVVVTIVCLDLGYTLKCNKLVPLFYKTCPAGKNLCYKMFMVSNLTVPVKRGCIDVCPKNSALVKYVCCNTDRC N 22 81 1CRE 1 60 P01442 A 1 1 60 2 3 anti-parallel anti-parallel anti-parallel A LYS 2 A LYS 2 A ASN 4 A ASN 4 A TYR 11 A TYR 11 A THR 13 A THR 13 A LEU 20 A LEU 20 A PHE 25 A PHE 25 A LYS 35 A LYS 35 A ILE 39 A ILE 39 A LYS 50 A LYS 50 A CYS 54 A CYS 54 1 P 1